Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of imrecoxib in volunteers with renal insufficiency
ChiCTR-RPC-17013177Phase 4Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of imrecoxib in Renal Insufficiency (RI) (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Plasma concentration of imrecoxib and Urine concentration of imrecoxib. Started Sep 2012; status: completed.
02
Drugs
imrecoxib
03
Conditions
Renal Insufficiency (RI)
Beyond the preview
Go deeper on ChiCTR-RPC-17013177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RPC-17013177.